|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn936547843 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
151106s2016 nyu ob 001 0 eng |
| 010 |
|
|
|a 2019719262
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d YDXCP
|d OCLCF
|d EBLCP
|d SNK
|d DKU
|d BTN
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781634842716
|q electronic bk.
|
| 020 |
|
|
|a 1634842715
|q electronic bk.
|
| 020 |
|
|
|z 9781634842709
|
| 020 |
|
|
|z 1634842707
|
| 029 |
1 |
|
|a AU@
|b 000062420136
|
| 035 |
|
|
|a (OCoLC)936547843
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC671
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.1
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Cardiac remodeling :
|b molecular mechanisms, treatment, and clinical implications /
|c Jerald Sherman, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Cardiology research and clinical developments
|
| 504 |
|
|
|a Includes bibliographical referenecs and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a CARDIAC REMODELING MOLECULAR MECHANISMS, TREATMENT AND CLINICAL IMPLICATIONS ; CARDIAC REMODELING MOLECULAR MECHANISMS, TREATMENT AND CLINICAL IMPLICATIONS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ABSTRACT; 1. INTRODUCTION; Cardiac Disease and ESRD; Uremic Cardiomyopathy ; Left Ventricular Hypertrophy ; Vascular Remodeling and ESRD ; Pathophysiology of the Changes in the Vascular System in ESRD Patients ; Clinical Readings of Arterial Remodeling
|
| 505 |
8 |
|
|a Peritoneal Dialysis and Cardiovascular Diseases Traditional Risk Factors in Patients on Peritoneal Dialysis ; 1. Arterial Hypertension ; 2. Atherosclerosis ; 3. Tobacco Smoking ; 4. Obesity ; 5. Dyslipidemia ; Uremia-Related Risk Factors ; 1. Inflammation; 2. Endothelial Dysfunction ; 3. Malnutrition and Protein-Energy Wasting; 4. Oxidative Stress ; 5. Calcification ; 6. Hyperparathyroidism ; 7. Hyperhomocysteinemia ; 8. Insulin Resistance ; 9. Anemia ; Risk Factors Related to Peritoneal Dialysis ; 1. Dialysis Solutions and Advanced Glycation End-Products
|
| 505 |
8 |
|
|a 2. Residual Renal Function (RRF) 3. Volume Overload and Ultrafiltration Insufficiency ; 4. Genetic and Epigenetic Factors ; 2. AIMS ; 3. METHODS ; Patients ; Echocardiographic Assessment ; Parameters of Peritoneal Dialysis ; Ultrasound Examination of the Carotid Arteries; Statistical Analysis ; 4. RESULTS ; Carotid Artery and Peritoneal Dialysis ; The Relation of Left Ventricular Alterations and Ultrasound Changes of Carotid Arteries in PD Patients ; 5. DISCUSSION ; REFERENCES ; Chapter 2 TROPOMYOSIN: AN EFFECTOR OF CARDIAC REMODELING ; ABSTRACT ; INTRODUCTION
|
| 505 |
8 |
|
|a TROPOMYOSIN STRUCTURE AND FUNCTION TPM ISOFORM EXPRESSION IN STRIATED MUSCLE ; TPM ISOFORM KNOCKOUTS AND OVEREXPRESSION IN MICE ; INVOLVEMENT OF TPM IN CARDIAC REMODELING HYPERTROPHY; RESCUE OF THE HCM PHENOTYPE ; INVOLVEMENT OF TPM IN DILATED CARDIOMYOPATHY REMODELING ; TPM PHOSPHORYLATION AND CARDIAC REMODELING ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 IMPACT OF VITAMIN D SYSTEM ON VENTRICULAR REMODELING ; ABSTRACT ; INTRODUCTION ; METABOLISM OF VITAMIN D ; VITAMIN D RECEPTOR ; VITAMIN D CIRCULATING LEVELS AND CARDIOVASCULAR DISEASE: CLINICAL EVIDENCES
|
| 505 |
8 |
|
|a VITAMIN D PATHWAY AND CARDIAC HYPERTROPHY CONCLUSION ; REFERENCES ; Chapter 4 EFFECTS OF COFFEE POLYPHENOLS ON MYOCARDIAL REMODELING; ABSTRACT ; 1. INTRODUCTION ; 2. EFFECTS OF CGA ON CARDIOVASCULAR DISEASES IN CLINICAL STUDIES; 3. EFFECTS OF CGA ON CARDIOVASCULAR DISEASES IN ANIMAL STUDIES; 4. CGA ON MYOCARDIAL INFARCTION ; 5. CGA ON MYOCARDITIS ; 6. FUTURE PERSPECTIVES ; CONCLUSION ; ACKNOWLEDGMENTS ; Grants ; REFERENCES ; INDEX
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Treatment.
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Diet therapy.
|
| 650 |
|
0 |
|a Ventricular remodeling.
|
| 650 |
|
2 |
|a Ventricular Remodeling
|
| 650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies
|x Traitement.
|
| 650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies
|x Diétothérapie.
|
| 650 |
|
6 |
|a Remodelage ventriculaire.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Treatment.
|2 fast
|0 (OCoLC)fst00847218
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Diet therapy.
|2 fast
|0 (OCoLC)fst00847190
|
| 650 |
|
7 |
|a Ventricular remodeling.
|2 fast
|0 (OCoLC)fst01738049
|
| 700 |
1 |
|
|a Sherman, Jerald,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Cardiac remodeling
|d New York : Nova Biomedical, [2016]
|z 9781634842709
|w (DLC) 2015956840
|
| 830 |
|
0 |
|a Cardiology research and clinical developments series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1164763
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12759154
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1164763
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4586168
|
| 994 |
|
|
|a 92
|b IZTAP
|
